Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Feinstein Bill To Mandate Fragrance Ingredient Contacts, Not Disclosure

Executive Summary

Cosmetics legislation poised for introduction in the Senate is likely to uphold the trade-secret status of fragrance compositions, promoting “a direct communication line” between FDA and fragrance houses rather than requiring full disclosure of fragrance ingredients, according to IFRA North America.

Advertisement

Related Content

Health Canada Targets Prohibited Substances In 'Fragrance'-Containing Cosmetics
Editorial: 'Stink!' Documentary On Fragrance Ills Presents Nothing New, Effectively
California Cleaning Products Bill Could Portend Broader Fragrance Disclosure
GOP Senate Takeover Makes Bipartisanship Crucial For Cosmetics Bill
Sen. Feinstein Plans Cosmetics Bill In Collaboration With Industry, NGOs
Women’s Voices Join In Fragrance Disclosure Debate, Citing Allergy Risks
Study Identifying "Secret" Chemicals In Popular Fragrances Spurs Legislation
Advertisement
UsernamePublicRestriction

Register

RS019408

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel